Search by Drug Name or NDC
NDC 57237-0301-24 Senna Syrup 8.8 mg/5mL Details
Senna Syrup 8.8 mg/5mL
Senna Syrup is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Rising Health, LLC. The primary component is SENNOSIDES.
MedlinePlus Drug Summary
Senna is used on a short-term basis to treat constipation. It also is used to empty the bowels before surgery and certain medical procedures. Senna is in a class of medications called stimulant laxatives. It works by increasing activity of the intestines to cause a bowel movement.
Related Packages: 57237-0301-24Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Senna
Product Information
| NDC | 57237-0301 |
|---|---|
| Product ID | 57237-301_f16c77f8-50d2-4ebf-b9ab-8512ee2044d2 |
| Associated GPIs | |
| GCN Sequence Number | 002922 |
| GCN Sequence Number Description | sennosides SYRUP 8.8MG/5ML ORAL |
| HIC3 | D6S |
| HIC3 Description | LAXATIVES AND CATHARTICS |
| GCN | 08660 |
| HICL Sequence Number | 001289 |
| HICL Sequence Number Description | SENNOSIDES |
| Brand/Generic | Generic |
| Proprietary Name | Senna Syrup |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Sennosides |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | LIQUID |
| Route | ORAL |
| Active Ingredient Strength | 8.8 |
| Active Ingredient Units | mg/5mL |
| Substance Name | SENNOSIDES |
| Labeler Name | Rising Health, LLC |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Listing Certified Through | 2024-12-31 |
Package
Package Images
NDC 57237-0301-24 (57237030124)
| NDC Package Code | 57237-301-24 |
|---|---|
| Billing NDC | 57237030124 |
| Package | 237 mL in 1 BOTTLE (57237-301-24) |
| Marketing Start Date | 2022-09-27 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.03753 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | SENNA 8.8 MG/5 ML SYRUP |
| Pharmacy Type Indicator | C/I |
| OTC | Y |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis
Standard Product Labeling (SPL)/Prescribing Information SPL dc636b83-6eca-412e-bac5-0c736b371ca7 Details
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
Warnings
Do not use laxative products for longer than 1 week unless directed by a doctor.
Ask a doctor before use if you have
- stomach pain, nausea or vomitting
- noticed a change in bowel habits that lasts over two weeks.
Stope use and ask a doctor if you have rectal bleeding or failure to have a bowel movement after use of laxative. These may indicate a serious condition.
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
Directions
- shake well before using
- Do not exceed recommended dose
| Age | Starting Dose | Maximum Dose |
| adults and children 12 years and older | 2 to 3 teaspoonfuls once a day preferably at bedtime; increase as needed or as recommended by a doctor | 3 teaspoonfuls in the morning and 3 teaspoonfuls at bedtime |
| Under 12 years of age | ask a doctor | ask a doctor |
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
INGREDIENTS AND APPEARANCE
| SENNA SYRUP
sennosides liquid |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
| Labeler - Rising Health, LLC (080500961) |
| Establishment | |||
| Name | Address | ID/FEI | Business Operations |
|---|---|---|---|
| Invahealth Inc. | 116840615 | analysis(57237-301) , label(57237-301) , manufacture(57237-301) , pack(57237-301) | |
Revised: 9/2022
Document Id: f16c77f8-50d2-4ebf-b9ab-8512ee2044d2
Set id: dc636b83-6eca-412e-bac5-0c736b371ca7
Version: 1
Effective Time: 20220920